• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ONCY

ONCY

Oncolytics Biotech Inc.

NASDAQHealthcareBiotechnologyCA

USD0.88

-0.05 (-5.13%)

Rating:C+

Company Profile

CEO

Jared Kelly

IPO Date

2001-10-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$0.95

Prev. Close

$0.93

Day Low

$0.88

Day High

$1.00

52W Low

$0.33

52W High

$1.51

Market Cap

$0.09B

Volume

1.55M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

37.0%

Avg Negative

1.6%

Avg Neutral

61.3%

News Feed

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights

PRNewsWire·7/22/2021·↑ positive

Oncolytics Biotech® to Present at the Ladenburg Thalmann Healthcare Conference

PRNewsWire·6/30/2021·↑ positive

Oncolytics Biotech (ONCY) Stock: Over 4% Increase Pre-Market Explanation

Pulse2·5/20/2021·↑ positive

Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer

PRNewsWire·5/20/2021·↑ positive

Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

PRNewsWire·5/13/2021·↓ negative

Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results

PRNewsWire·5/7/2021·↑ positive

Oncolytics Biotech® Announces Annual General Meeting

PRNewsWire·4/30/2021·↓ negative

Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting

PRNewsWire·4/29/2021·↑ positive

Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study

PRNewsWire·4/12/2021·↑ positive

Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting

PRNewsWire·4/12/2021·↑ positive